Téléchargez le livre : Developing Therapeutics for Alzheimer's Disease

Developing Therapeutics for Alzheimer's Disease

Progress and Challenges

de

Éditeur :

Academic Press


Paru le : 2016-05-27



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈 ebook sans DRM
Lecture en ligne (streaming)
150,86 €
Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

badge apple Application Louise Reader
badge Android Application Louise Reader
Description
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer's disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area. Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer's disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer's disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics. - Provides a realistic but promising assessment of the potential of various therapeutic approaches to Alzheimer's disease - Focuses primarily on neuroprotective agents and cognitive enhancers, as well as approaches to targeting the amyloid B-peptide, tau and Apolipoprotein E - Discusses alternative approaches, preclinical and clinical development issues, related biomarkers and diagnostics, and prevention and nonpharmacological approaches
Pages
676 pages
Collection
n.c
Parution
2016-05-27
Marque
Academic Press
EAN papier
9780128021736
EAN PDF
9780128021644
Informations sur l'ebook
Nombre pages copiables
67
Nombre pages imprimables
67
Taille du fichier
22385 Ko
Ce livre est accessible aux handicaps Voir les informations sur l'accessibilité
Prix
150,86 €
EAN EPUB SANS DRM
9780128021644
Informations sur l'ebook
Ce livre est accessible aux handicaps Voir les informations sur l'accessibilité
Prix
150,86 €

Suggestions personnalisées